Chris BoyleAssociate, Life Sciences IP Regulatory at Sidley Austin LLP
Chris is a life sciences lawyer focusing on advising and litigating in the highly regulated fields of human and veterinary medicinal products and medical devices. The clinical experience Chris gained as a veterinary surgeon is a particular asset to his practice.
Chris is experienced in representing clients before both the UK and EU courts. In particular, he represents a pharmaceutical company in high value follow-on damages proceedings in the UK concerning the intersection between competition, regulatory and patent law. Chris has also successfully enforced orphan drug market exclusivity before the General Court in Luxembourg.
Chris advises across a broad spectrum of life science regulatory matters. In the human health field this includes advising on the orphan, paediatric, SPC and regulatory data protection/marketing protection frameworks and extends to advertising, medical devices, product liability, market access and data transparency issues. In the animal health field, Chris advises pharmaceutical, feed and medical device companies on a diverse range of issues including advertising and promotion, off-label prescribing, extemporaneously prepared veterinary medicines and novel routes to market.
Chris regularly presents on hot topics in the regulatory life sciences sector and launched a first of its kind animal health legal and commercial day in 2017. Chris has authored an orphan drug chapter in the Oxford University Press textbook "Navigating European Pharmaceutical Law."